HR 2586, the Reentry Act of 2025, amends Medicaid rules to allow incarcerated individuals to receive Medicaid coverage during the 30 days immediately before their release from prison or jail. This directly affects people leaving correctional facilities, ensuring they can access health care as they transition back into communities. The bill requires a report within 18 months analyzing current health care standards in prisons, the number of people who would gain coverage, and current discharge practices to improve Medicaid enrollment for newly released individuals. The report will also assess how to better connect people with community health services and addiction treatment after release.
HR 7145 defines "essential health systems" as hospitals serving large numbers of Medicaid and low-income patients, specifically targeting non-Federal, nonprofit, or government-run hospitals that meet one of three criteria for at least two of the past three years (e.g., high Medicaid patient percentage, high uncompensated care, or top 16th percentile in state rankings for low-income care). The bill requires MACPAC to annually publish an "essential health system index" ranking qualifying hospitals nationally, by state, and within local areas, using data from Medicare reporting. Hospitals designated as essential health systems receive a five-year designation, renewable if they maintain eligibility. This framework aims to identify facilities providing critical community care for vulnerable populations through standardized metrics.
This bill amends Medicare and Medicaid regulations to clarify the conditions under which skilled nursing facilities lose approval for nurse training programs. It updates the criteria to include facilities assessed with a civil penalty of at least $12,924 for quality-of-care deficiencies or subject to specific corrective remedies. The changes refine the existing penalty thresholds and deficiency types that trigger loss of program approval. This is a technical regulatory adjustment affecting nursing facilities' compliance status under federal healthcare programs, not a new policy or funding measure.
This bill requires psychiatric hospitals to have their accreditation inspections documented using a standardized form (CMS-2567 or a future successor) starting two years after enactment. It mandates that the Centers for Medicare & Medicaid Services publish key inspection findings on the Care Compare website two years after enactment, helping healthcare consumers compare facilities. The law includes privacy safeguards to prevent disclosure of patient or staff identities, ensuring compliance with HIPAA regulations. The bill directly affects psychiatric hospitals, accreditation bodies, and patients seeking care, by increasing transparency around facility inspections.
This bill requires Medicaid programs to cover lung cancer biomarker testing for eligible enrollees, beginning January 1, 2027. It directly affects Medicaid recipients diagnosed with lung cancer who need these specific tests to guide treatment decisions. The key provision adds "lung cancer biomarker testing" as a mandatory benefit under Medicaid, amending the Social Security Act to require coverage for this diagnostic service. The change applies to all state Medicaid programs participating in the federal program, ensuring standardized access to this testing method. Coverage starts in 2027, with no additional state cost-sharing required for this specific test.
The Health Care Fairness for All Act repeals the individual and employer health insurance mandates from the Affordable Care Act. It creates a new tax credit to help people afford health insurance and modifies health savings accounts to make them more accessible. The bill maintains certain consumer protections like no lifetime coverage limits and coverage for dependents up to age 26, while giving states more flexibility to regulate health insurance outside of the ACA marketplace. It also includes changes to Medicare and Medicaid payment systems to improve cost transparency and quality of care.
This bill sets annual reference prices for prescription drugs based on the lowest prices in specific countries (like Canada, UK, and Germany), preventing manufacturers from charging more than this price for drugs covered under major federal health programs. It directly affects Medicare, Medicaid, VA care, TRICARE, and other federal health programs by capping drug costs at the reference price. Manufacturers must sell drugs at or below this reference price to all patients, including those without insurance, with civil penalties of up to five times the revenue difference for non-compliance. Collected penalties fund drug research through the National Institutes of Health.
HR 6167, the HEALTH Act of 2025, creates a new tax deduction for physicians providing unreimbursed charity care to patients enrolled in Medicaid (Title XIX) or CHIP (Title XXI) programs. The deduction equals the Medicare fee schedule amount for such care, but excludes services like sex reassignment surgeries and hormone treatments for gender transition. Additionally, the bill adds liability protection for physicians providing this charity care, shielding them from civil lawsuits for non-intentional harm during such services, and preempts conflicting state laws. This directly affects physicians who serve low-income patients through public health programs.
SJRES 84 is a joint resolution seeking to block a rule issued by the Centers for Medicare & Medicaid Services (CMS) under the Affordable Care Act. The rule, published in the Federal Register on June 25, 2025, aimed to improve affordability and integrity in health insurance marketplaces. If approved, this resolution would invalidate the rule under a federal disapproval process, preventing its implementation. This directly affects how health insurance plans are structured and priced for consumers using ACA marketplaces.
This bill repeals two provisions from a previous reconciliation act that reduced Medicaid funding flexibility for states and rescinds related funds. It directly affects Medicaid programs and rural hospitals by restoring prior funding structures and adding $10 billion annually from 2031 through 2035 to the Rural Health Transformation Program. Key mechanisms include undoing changes to state Medicaid provider tax authority and state-directed payments, while increasing annual funding for rural hospital support. The bill makes concrete policy changes by reversing specific funding cuts and guaranteeing new, sustained investment for rural healthcare facilities.
